Exit Axial, enter Vertero: Biotech rebrands, refocuses and raises $20M
21st October 2025 Uncategorised 0Axial Therapeutics has stepped back into the spotlight, emerging after almost two years of silence with a new name, focus and financing.
More: Exit Axial, enter Vertero: Biotech rebrands, refocuses and raises M
Source: fierce
